| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -7041.2% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 16.0 | n/a |
| Pr/Book | 0.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 500.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | n/a | (0.76) | (1.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.03 | (5.90) | (0.04)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.02 | (8.81) | (0.05)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 0.02 | (6.34) | (4.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.11 | (7.78) | (5.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Issue of Equity - Conversion of Loan Notes | 28-Apr-2026 | 07:00 | RNS |
| Issue of Equity - Conversion of Loan Notes | 15-Apr-2026 | 07:00 | RNS |
| Pfizer Licensing Agreement Renewal | 13-Apr-2026 | 07:00 | RNS |
| Issue of Equity - Conversion of Loan Notes | 10-Mar-2026 | ShareCast |
| Holding(s) in Company | 10-Mar-2026 | ShareCast |
| Trellus Health reports operational, commercial p... | 03-Feb-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.14p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.85 |
| 52 Week Low | 0.13 |
| Volume | 3,144,468 |
| Shares Issued | 430.12m |
| Market Cap | £0.60m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:32 | 10,918 @ 0.13p |
| 13:23 | 50,000 @ 0.15p |
| 12:37 | 375 @ 0.13p |
| 12:29 | 948 @ 0.13p |
| 11:25 | 603,183 @ 0.14p |
You are here: research